Clinical Trials Directory

Trials / Completed

CompletedNCT07011030

Diagnosis of Sarcopenia in Older Adults

Comparison of the Use of a Bioimpedance Meter With Integretaed Electrodes and Osteodensitometry for the Diagnosis os Sarcopenia in the Elderly

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

Sarcopenia is defined as the loss of muscle strength and mass associated with aging and is one of the main causes of frailty in older people, and therefore of their ability to age gracefully. Given the aging of the French population, the diagnosis and management of this condition is a major public health issue and, in this context, it is therefore necessary to be able to quickly assess people's skeletal muscle mass. In its recommendations, French National Authority for Health recommends the use osteodensitometry and bioimpedance analysis (BIA) to assess skeletal muscle mass in the limbs for the purpose of diagnosing sarcopenia. Traditionally, BIA assessment is performed while lying down using adhesive electrodes placed on the hands and feet. The Biody XpertZM3 is a BIA device that allows seated measurement using integrated electrodes, enabling skeletal muscle mass to be assessed by bioimpedance analysis without the use of adhesive electrodes. However, the measurement position could alter the impedances measured and therefore the results obtained compared to other devices on the market as well as osteodensitometer

Conditions

Interventions

TypeNameDescription
OTHERMeasure of skeletal muscle massBioimpedance analysis with integrated electrodes and osteodensitometry examination

Timeline

Start date
2025-09-23
Primary completion
2025-12-04
Completion
2025-12-04
First posted
2025-06-08
Last updated
2025-12-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07011030. Inclusion in this directory is not an endorsement.